Evidence, Outcomes and Practical Guidance to SABR in Primary Renal Cell Carcinoma for Your Clinic

Accuray October 17th, 2024

October 17th 2024, 7am PDT | 10am EDT | 4pm CEST | 10pm HKT

Presenters: Shankar Siva, Ph.D., MBBS, FRANZCR, Professor, Radiation Oncologist, Peter MacCallum Cancer Centre, Australia

Moderator: Alexander Muacevic, M.D. Professor, European Radiosurgery Center Munich, Germany

Summary: The learning objectives for this webinar include:

  • Reviewing the role of stereotactic body radiotherapy (SBRT) in the multidisciplinary management of kidney cancer.
  • Outlining the principles of SBRT for managing primary renal cell carcinoma.
  • Reviewing treatment regimens, the role of post-treatment biopsy and nephron-sparing approaches.

 

This webinar is pending approval from CAMPEP for 1 MPCEC hour and approved by ASRT for 1 category A credit.

DISCLAIMER: The statements and articles in the corporate news forum do not necessarily reflect the views of, and are not endorsed by ISRS. Please consult the specific corporate entity for relevant disclosures and restrictions related to these news features.